Seong-yun Jeong

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications

Comparative Preclinical Evaluation of BIX-01294 and UNC0642 as EHMT2-Targeting Anticancer Agents.

Comparative Preclinical Evaluation of BIX-01294 and UNC0642 as EHMT2-Targeting Anticancer Agents.

Journal: Cancers
Published: March 26, 2026

Integrative multi-omics stratification and translational evaluation of Treg-targeted combination immunotherapy in breast cancer.

Integrative multi-omics stratification and translational evaluation of Treg-targeted combination immunotherapy in breast cancer.

Journal: Frontiers in oncology
Published: October 24, 2025

Silencing of NUP62 overcomes osimertinib resistance via ubiquitination of survivin in non-small cell lung cancer cells.

Silencing of NUP62 overcomes osimertinib resistance via ubiquitination of survivin in non-small cell lung cancer cells.

Journal: British journal of cancer
Published: August 22, 2025

Ibulocydine Inhibits Migration and Invasion of TNBC Cells via MMP-9 Regulation.

Ibulocydine Inhibits Migration and Invasion of TNBC Cells via MMP-9 Regulation.

Journal: International journal of molecular sciences
Published: April 25, 2024

Evaluation of Foot-and-Mouth Disease (FMD) Virus Asia1 Genotype-V as an FMD Vaccine Candidate: Study on Vaccine Antigen Production Yield and Inactivation Kinetics.

Evaluation of Foot-and-Mouth Disease (FMD) Virus Asia1 Genotype-V as an FMD Vaccine Candidate: Study on Vaccine Antigen Production Yield and Inactivation Kinetics.

Journal: Vaccines
Published: January 15, 2024

Determination of Optimal Antigen Yield and Virus Inactivation Conditions for the Production of the Candidate Foot-and-Mouth Disease Recombinant Vaccine Strain Asia1 Shamir-R in a Bioreactor.

Determination of Optimal Antigen Yield and Virus Inactivation Conditions for the Production of the Candidate Foot-and-Mouth Disease Recombinant Vaccine Strain Asia1 Shamir-R in a Bioreactor.

Journal: Viruses
Published: January 15, 2024

Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis.

Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis.

Journal: Cell death & disease
Published: June 20, 2023

ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors.

ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors.

Journal: Cancer cell international
Published: May 23, 2023

Orthotopic model of pancreatic cancer using CD34+ humanized mice and generation of tumor organoids from humanized tumors.

Orthotopic model of pancreatic cancer using CD34+ humanized mice and generation of tumor organoids from humanized tumors.

Journal: International immunopharmacology
Published: April 04, 2023

Targeting phosphomevalonate kinase enhances radiosensitivity via ubiquitination of the replication protein A1 in lung cancer cells.

Targeting phosphomevalonate kinase enhances radiosensitivity via ubiquitination of the replication protein A1 in lung cancer cells.

Journal: Cancer science
Published: February 16, 2023

NCK-associated protein 1 regulates metastasis and is a novel prognostic marker for colorectal cancer.

NCK-associated protein 1 regulates metastasis and is a novel prognostic marker for colorectal cancer.

Journal: Cell death discovery
Published: November 01, 2022

PAUF as a Target for Treatment of High PAUF-Expressing Ovarian Cancer.

PAUF as a Target for Treatment of High PAUF-Expressing Ovarian Cancer.

Journal: Frontiers in pharmacology
Published: March 06, 2022
Showing 1-12 of 70

Last Updated: 09/26/2026